(Total Views: 900)
Posted On: 02/02/2018 6:56:49 PM
Post# of 132
NetworkNewsBreaks – Grey Cloak Tech, Inc.’s (GRCK) Eqova Life Sciences Provides Quality CBD Products
Last October, Grey Cloak Tech (OTCQB: GRCK) entered the CBD market sector through its acquisition of Eqova Life Sciences, an established producer of a wide range of clinical-grade hemp CBD oil products supplying medical practitioners. An article discussing the company reads: “Eqova’s products are not developed for recreational use, and the company only uses natural, standardized phytocannabinoid-rich hemp oil in its medical-grade, CBD-based products. It employs a rigorous product development cycle, where each ingredient is studied in isolation and in the context of other ingredients, use case and delivery method. Eqova has developed cutting-edge delivery methods for oral, topical, liposomal and sublingual applications. The company’s innovative products and commitment to stringent quality control ensures that medical practitioners receive high quality, consistent pharmaceutical-grade ingredients with standardized dosing to help their patients.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Last October, Grey Cloak Tech (OTCQB: GRCK) entered the CBD market sector through its acquisition of Eqova Life Sciences, an established producer of a wide range of clinical-grade hemp CBD oil products supplying medical practitioners. An article discussing the company reads: “Eqova’s products are not developed for recreational use, and the company only uses natural, standardized phytocannabinoid-rich hemp oil in its medical-grade, CBD-based products. It employs a rigorous product development cycle, where each ingredient is studied in isolation and in the context of other ingredients, use case and delivery method. Eqova has developed cutting-edge delivery methods for oral, topical, liposomal and sublingual applications. The company’s innovative products and commitment to stringent quality control ensures that medical practitioners receive high quality, consistent pharmaceutical-grade ingredients with standardized dosing to help their patients.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
